Clinical Trial Update: The TCF7L2 Gene: Dietary Prevention of T2DM [NA]

View source ↗

Summary

Clinical trial NCT03458494 on dietary prevention related to the TCF7L2 gene for type 2 diabetes has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperglycemia
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Tufts University | Conditions: Type2 Diabetes, Glucose, High Blood | NA | Status: TERMINATED